eXoZymes, Inc.
EXOZ
$6.17
-$0.14-2.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -13.15% | -7.97% | 17.02% | 46.97% | 59.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.93% | 22.37% | 35.91% | 56.49% | 91.78% |
| Operating Income | -15.93% | -22.37% | -35.91% | -56.49% | -91.78% |
| Income Before Tax | -21.96% | -27.68% | -50.17% | -38.07% | -73.76% |
| Income Tax Expenses | -- | -- | -4,909.52% | -- | -- |
| Earnings from Continuing Operations | -21.96% | -27.68% | -44.61% | -38.07% | -73.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.96% | -27.68% | -44.61% | -38.07% | -73.49% |
| EBIT | -15.93% | -22.37% | -35.91% | -56.49% | -91.78% |
| EBITDA | -16.20% | -23.01% | -36.86% | -58.84% | -96.41% |
| EPS Basic | -18.00% | -26.27% | -29.21% | -2.94% | -29.46% |
| Normalized Basic EPS | -17.94% | -26.24% | -34.14% | -2.90% | -29.68% |
| EPS Diluted | -18.00% | -26.27% | -29.21% | -2.94% | -29.46% |
| Normalized Diluted EPS | -17.94% | -26.24% | -34.14% | -2.90% | -29.68% |
| Average Basic Shares Outstanding | 3.38% | 1.09% | 11.92% | 34.15% | 34.01% |
| Average Diluted Shares Outstanding | 3.38% | 1.09% | 11.92% | 34.15% | 34.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |